⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9635 | 0.77 | — | — | |
| Ammonia Solution, Strong SCHEMBL10454832 | 0.74 | — | — | |
| SCHEMBL9717355 | 0.72 | — | — | |
| SCHEMBL4801334 | 0.72 | — | — | |
| SCHEMBL2143466 | 0.72 | — | — | |
| SCHEMBL2106867 | 0.72 | — | — | |
| SCHEMBL9774990 | 0.72 | — | — | |
| SCHEMBL3302971 | 0.72 | — | — | |
| SCHEMBL6590038 | 0.69 | — | — | |
| Dimethyl Sulfoxide SCHEMBL20866176 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240216350-A1 | SEMI-SOLID TOPICAL COMPOSITION CONTAINING PIRFENIDONE AND MODIFIED DIALLYL DISULFIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE | EXCALIBUR PHARMACEUTICALS, INC. (US) | 2024-07-04 | — | — | US | claimed |
| EP-4284897-A1 | STEAM CRACKING PROCESS INTEGRATING OXIDIZED DISULFIDE OIL ADDITIVE | Saudi Arabian Oil Company (SA) | 2023-12-06 | — | — | EP | claimed |
| US-20210401989-A1 | SEMI-SOLID, OIL-BASED PHARMACEUTICAL COMPOSITIONS CONTAINING PIRFENIDONE FOR APPLICATION IN TISSUE REPAIR | EXCALIBUR PHARMACEUTICALS, INC. (US) | 2021-12-30 | — | — | US | claimed |
| EP-3842030-A2 | SEMI-SOLID, OIL-BASED PHARMACEUTICAL COMPOSITIONS CONTAINING PIRFENIDONE FOR APPLICATION IN TISSUE REPAIR | EXCALIBUR PHARMACEUTICALS, INC. (US) | 2021-06-30 | — | — | EP | claimed |
| CN-111246840-A | Topical semi-solid compositions comprising an antimicrobial agent and pirfenidone for the treatment of chronic skin lesions | 细胞治疗技术合伙股份有限公司 | 2020-06-05 | — | — | CN | claimed |
| US-20200061040-A1 | SEMI-SOLID TOPICAL COMPOSITION CONTAINING PIRFENIDONE AND MODIFIED DIALLYL DISULFIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE | Cell Therapy and Technology S.A. DE C.V. (MX) | 2020-02-27 | — | — | US | claimed |
| US-20180214434-A1 | SEMI-SOLID TOPICAL COMPOSITION CONTAINING PIRFENIDONE AND MODIFIED DIALLYL DISULFIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE | EXCALIBUR PHARMACEUTICALS, INC. | 2018-08-02 | — | — | US | claimed |
| US-20160228424-A1 | SEMI-SOLID TOPICAL COMPOSITION CONTAINING PIRFENIDONE AND MODIFIED DIALLYL DISULFIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE | EXCALIBUR PHARMACEUTICALS, INC. | 2016-08-11 | — | — | US | claimed |
| US-20150148382-A1 | SEMI-SOLID TOPICAL COMPOSITION WHICH CONTAINS PIRFENIDONE AND MODIFIED DIALLYL DISULPHIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE | EXCALIBUR PHARMACEUTICALS, INC. | 2015-05-28 | — | — | US | claimed |
| EP-2832354-A1 | SEMI-SOLID TOPICAL COMPOSITION WHICH CONTAINS PIRFENIDONE AND MODIFIED DIALLYL DISULPHIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE | Cell Therapy and Technology S.A. de C.V. (MX) | 2015-02-04 | — | — | EP | claimed |
| CN-104334171-A | Semi-solid topical composition which contains pirfenidone and modified diallyl disulphide oxide (m-ddo) for eliminating or preventing acne | CELL THERAPY AND TECHNOLOGY S A DE C V | 2015-02-04 | — | — | CN | claimed |
| US-20240216350-A1 | SEMI-SOLID TOPICAL COMPOSITION CONTAINING PIRFENIDONE AND MODIFIED DIALLYL DISULFIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE | EXCALIBUR PHARMACEUTICALS, INC. (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240216350-A1 | SEMI-SOLID TOPICAL COMPOSITION CONTAINING PIRFENIDONE AND MODIFIED DIALLYL DISULFIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE | EXCALIBUR PHARMACEUTICALS, INC. (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240216350-A1 | SEMI-SOLID TOPICAL COMPOSITION CONTAINING PIRFENIDONE AND MODIFIED DIALLYL DISULFIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE | EXCALIBUR PHARMACEUTICALS, INC. (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240175105-A1 | LEACHING AGENT COMPOSITION AND METHOD OF REMOVING METAL FROM CATALYST MATERIAL | SAUDI ARABIAN OIL COMPANY (SA) | 2024-05-30 | — | — | US | disclosed |
| WO-1997039355-A1 | PHARMACEUTICAL GRADE BOTANICAL DRUGS | PHARMAPRINT, INC. (US) | 1997-10-23 | — | — | WO | disclosed |
| WO-1997039115-A1 | IMMOBILIZED ALLIINASE AND CONTINUOUS PRODUCTION OF ALLICIN | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1997-10-23 | — | — | WO | disclosed |
| US-5321045-A | PAF-induced bronchial obstructions | BOEHRINGER MANNHEIM GMBH (DE) | 1994-06-14 | — | — | US | disclosed |
| US-4665088-A | ANTICOAGULANTS | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1987-05-12 | — | — | US | disclosed |
| US-4665088-A | ANTICOAGULANTS | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1987-05-12 | — | — | US | disclosed |